From: Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study
 | Total number of IBD patients | Patients with Ulcerative colitis | Patients with Crohn’s disease | ||
---|---|---|---|---|---|
Severity at diagnosis of IBD | Â | According to MAYO score 48% (166/346) Mild 29% (100/346) Moderate 23% (80/346) Severe | According to CDAI score 27% (69/256) Mild 41% (105/256) Moderate 32% (82/256) Severe | ||
Localization | Â | 24% (83/346) Proctitis 41% (142/346) Left sided colitis 35% (121/346) Pancolitis | 29% (74/256) Ileitis 38% (97/256) Colitis 33% (85/256) Ileitis and colitis | ||
Age at diagnosis | 39 (Std. Dev. 17.4) | 42 (Std. Dev. 18.9) | 35 (Std. Dev. 16.3) | ||
Sex (Male/Female) | 360 (60%)/ 242 (40%) | 202 (58%) /144 (42%) | 162 (63%) /94 (37%) | ||
Fatty liver | 44 (20%, 44/220) | 28 | (26.2%, 28/107) | 16 | (14.2%, 16/113) |
Hemangioma | 11 (5%, 11/220) | 7 | (6.5%, 7/107) | 4 | (3.5%, 4/113) |
Cyst | 14 (6.3%, 14/220) | 8 | (7.5%, 8/107) | 6 | (5.3%, 6/113) |
Multiple liver abscesses | 1 (0.4%, 1/220) | 0 | (0%) | 1 | (0.9%, 1/113) |
Fibrosis | 1 (0.4%, 1/220) | 0 | (0%) | 1 | (0.9%, 1/113) |
Cirrhosis | 1 (0.4%, 1/220) | 0 | (0%) | 1 | (0.9% 1/113) |
Portal vein thrombosis | 1 (0.4%, 1/220) | 1 | (0.9%, 1/107) | 0 | (0%) |
Cholelithiasis | 32 (14.5%, 32/220) | 12 | (11.2%, 12/107) | 20 | (17.7%, 20/113) |
Primary sclerosing cholangitis | 7 (3.2%, 7/220) | 2 | (1.9%, 2/107) | 5 | (4.4%, 5/113) |
Cholecystitis | 7 (3.2%, 7/220) | 3 | (2.8%, 3/107) | 4 | (3.5%, 4/113) |
Polyps in the gallbladder | 5 (2.3%, 5/220) | 4 | (3.7%, 4/107) | 1 | (0.9%, 1/113) |
Cholangiocarcinoma | 1 (0.4%, 1/220) | 1 | (0.9%, 1/107) | 0 | (0%) |
Acute pancreatitis | 4 (1.8%, 4/220) | 0 | (0%) | 4 | (3.5%, 4/113) |
Fatty pancreas | 2 (0.9%, 2/220) | 1 | (0.9%, 1/107) | 0 | (0%) |
Chronic pancreatitis | 1 (0.4%, 1/220) | 1 | (0.9%, 1/107) | 0 | (0%) |